Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd (SHE:301130)
China · Delayed Price · Currency is CNY 22.24
-0.59 (-2.58%)
Jul 30, 2026, 3:04 PM CST
SHE:301130 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 238.55 | 234.84 | 256.41 | 225.49 | 255.47 | 285.66 |
Revenue Growth | -1.39% | -8.41% | 13.71% | -11.73% | -10.57% | -0.23% |
Gross Profit Gross Profit Growth | 178.67 | 177.8 | 195.24 | 179.97 | 208.05 | 238.68 |
Operating Income Operating Income Growth | 17.45 | 15.7 | 37.57 | 26.77 | 36.28 | 48.25 |
Net Income Net Income Growth | 22.79 | 21.9 | 40.27 | 50.5 | 40.72 | 52.02 |
Earnings Per Share EPS Growth | 0.30 | 0.29 | 0.52 | 0.63 | 0.53 | 0.86 |
EPS Growth | -33.73% | -44.66% | -17.23% | 18.84% | -38.73% | 4.58% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Pharmaceuticals Pharmaceuticals Growth | 238.1 | 234.4 | 255.25 | 225.14 | 255.4 | 285.14 |
Unallocated Other Business Unallocated Other Business Growth | - | 0.44 | 1.16 | 0.35 | 0.07 | 0.51 |
Total Total Growth | 238.55 | 234.84 | 256.41 | 225.49 | 255.47 | 285.66 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 222.05 | 236.46 | 275.65 | 550.28 | 616.08 | 215.2 |
Total Debt Total Debt Growth | 39.59 | 11.61 | 10.2 | 0.32 | - | - |
Net Cash (Debt) Net Cash Growth | 182.46 | 224.85 | 265.46 | 549.96 | 616.08 | 215.2 |
Net Cash Growth | -28.06% | -15.30% | -51.73% | -10.73% | 186.28% | 22.20% |
Net Cash Per Share Net Cash Per Share Growth | 2.39 | 2.94 | 3.41 | 6.81 | 7.96 | 3.55 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 50.44 | 48.62 | 54.24 | 54.39 | 67.23 | 59.01 |
Capital Expenditures CapEx Growth | -67.78 | -66.06 | -134.97 | -123.17 | -54.4 | -21.18 |
Free Cash Flow Free Cash Flow Growth | -17.34 | -17.44 | -80.73 | -68.79 | 12.83 | 37.83 |
Free Cash Flow Growth | - | - | - | - | -66.09% | -24.39% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 74.90% | 75.71% | 76.15% | 79.81% | 81.44% | 83.55% |
Operating Margin | 7.31% | 6.69% | 14.65% | 11.87% | 14.20% | 16.89% |
Pretax Margin | 9.26% | 8.94% | 18.14% | 25.86% | 19.74% | 20.73% |
Profit Margin | 9.55% | 9.32% | 15.71% | 22.40% | 15.94% | 18.21% |
FCF Margin | -7.27% | -7.43% | -31.49% | -30.51% | 5.02% | 13.24% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.145 | 0.145 | 0.260 | 0.260 | 0.160 | 0.130 |
Dividend Per Share Growth | -44.23% | -44.23% | 0% | 62.50% | 23.08% | - |
Dividend Yield | 0.64% | 0.51% | 1.00% | 0.96% | 0.57% | - |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 74.64 | 99.69 | 49.90 | 44.61 | 57.29 | - |
P/FCF Ratio | - | - | - | - | 181.84 | - |
PS Ratio | 7.04 | 9.30 | 7.84 | 9.99 | 9.13 | - |